Obeng-Adjei Nyamekye, Portugal Silvia, Tran Tuan M, Yazew Takele B, Skinner Jeff, Li Shanping, Jain Aarti, Felgner Philip L, Doumbo Ogobara K, Kayentao Kassoum, Ongoiba Aissata, Traore Boubacar, Crompton Peter D
Malaria Infection Biology and Immunity Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20852, USA.
Division of Infectious Diseases, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Cell Rep. 2015 Oct 13;13(2):425-39. doi: 10.1016/j.celrep.2015.09.004. Epub 2015 Oct 1.
Malaria-specific antibody responses are short lived in children, leaving them susceptible to repeated bouts of febrile malaria. The cellular and molecular mechanisms underlying this apparent immune deficiency are poorly understood. Recently, T follicular helper (Tfh) cells have been shown to play a critical role in generating long-lived antibody responses. We show that Malian children have resting PD-1(+)CXCR5(+)CD4(+) Tfh cells in circulation that resemble germinal center Tfh cells phenotypically and functionally. Within this population, PD-1(+)CXCR5(+)CXCR3(-) Tfh cells are superior to Th1-polarized PD-1(+)CXCR5(+)CXCR3(+) Tfh cells in helping B cells. Longitudinally, we observed that malaria drives Th1 cytokine responses, and accordingly, the less-functional Th1-polarized Tfh subset was preferentially activated and its activation did not correlate with antibody responses. These data provide insights into the Tfh cell biology underlying suboptimal antibody responses to malaria in children and suggest that vaccine strategies that promote CXCR3(-) Tfh cell responses may improve malaria vaccine efficacy.
儿童体内针对疟疾的抗体反应持续时间较短,这使得他们容易反复出现发热性疟疾发作。这种明显免疫缺陷背后的细胞和分子机制尚不清楚。最近,滤泡辅助性T(Tfh)细胞已被证明在产生长效抗体反应中起关键作用。我们发现,马里儿童循环中存在静息的PD-1(+)CXCR5(+)CD4(+) Tfh细胞,其在表型和功能上类似于生发中心Tfh细胞。在这一群体中,PD-1(+)CXCR5(+)CXCR3(-) Tfh细胞在辅助B细胞方面优于Th1极化的PD-1(+)CXCR5(+)CXCR3(+) Tfh细胞。纵向观察发现,疟疾会引发Th1细胞因子反应,因此,功能较弱的Th1极化Tfh亚群被优先激活,且其激活与抗体反应无关。这些数据为儿童对疟疾抗体反应欠佳背后的Tfh细胞生物学提供了见解,并表明促进CXCR3(-) Tfh细胞反应的疫苗策略可能会提高疟疾疫苗的效力。